Investing.com -- Telomir Pharmaceuticals Inc (NASDAQ:TELO)股价跳涨15%,此前这家临床前阶段生物技术公司宣布了新的研究结果,显示其主要化合物能够恢复亨廷顿-吉尔福德早衰综合症(HGPS)患者细胞的线粒体功能。 该公司的化合物Telomir-1展示了在不触发氧化应激或细胞增殖的情况下恢复病变细胞能量的能力。这项研究与Smart ...
Source LinkInvesting.com -- Telomir Pharmaceuticals Inc (NASDAQ:TELO)股价跳涨15%,此前这家临床前阶段生物技术公司宣布了新的研究结果,显示其主要化合物能够恢复亨廷顿-吉尔福德早衰综合症(HGPS)患者细胞的线粒体功能。 该公司的化合物Telomir-1展示了在不触发氧化应激或细胞增殖的情况下恢复病变细胞能量的能力。这项研究与Smart ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.